(19)
(11) EP 1 064 301 A1

(12)

(43) Date of publication:
03.01.2001 Bulletin 2001/01

(21) Application number: 99910541.4

(22) Date of filing: 18.03.1999
(51) International Patent Classification (IPC)7C07K 14/00
(86) International application number:
PCT/GB9900/850
(87) International publication number:
WO 9947/553 (23.09.1999 Gazette 1999/38)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 18.03.1998 GB 9805792

(71) Applicant: GLAXO GROUP LIMITED
Greenford, Middlesex UB6 ONN (GB)

(72) Inventors:
  • ARIGONI, Fabrizio
    CH-1204 Geneva (CH)
  • EDGERTON, Michael David
    62 Maritime Drive,Mystic, CT 06355 (US)
  • LOFERER, Hannes
    D-82538 Geretsried (DE)
  • PEITSCH, Manuel, C.
    CH-1855 La Forclaz (CH)

(74) Representative: Rees, Marion Lindsay 
Glaxo Wellcome plc,Glaxo Wellcome House,Intellectual Property Department,Berkeley Avenue
Greenford,Middlesex UB6 0NN
Greenford,Middlesex UB6 0NN (GB)

   


(54) BACTERIAL YAEL FAMILY MEMBERS AS TARGETS FOR ANTIMICROBIAL DRUG DESIGN